Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Insights
  3. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • NHS Solutions
  • Life Sciences Industry
  • Advancing UK Healthcare
  • Pharmacy Communications
NHS Solutions

Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.

Learn More
NHS Solutions
Life Sciences Industry

We believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.

Learn More
Life Sciences Industry Solutions
Advancing UK Healthcare

We are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.

Learn More
Advancing UK Healthcare Solutions
Pharmacy Communications

IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.

Learn More
MAIN/Insights
Insights/
BLOGS, WHITEPAPERS & CASE STUDIES

Explore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.

Learn More
NEWSROOM

Stay up to date on the latest news and press releases from IQVIA UK & Ireland.

Learn More

Report

"Our commitment to sustainability.

Learn More
MAIN/Contact Us
Contact Us/
White Paper
Excellent launches are winning the evidence battle
Beyond necessity and nice to have: RWE as a true strategic differentiator
Mar 09, 2020
To download files, please accept Functional Cookies. These cookies provide enhanced functionality for a better user experience.

Launch Excellence has acquired an almost mythical quality: pursued by many, found by few, as we have observed in our most recent white paper on this topic. The pharmaceutical industry's quest for launch excellence has spurred a wealth of publications on how to achieve it, yet little has been written on the competitive use of real world evidence (RWE), as a true strategic differentiator, in the launch context.

In this white paper, we will explore the critical importance of RWE as a source of competitive advantage, how excellent launches have utilised it in achieving success and address key questions, such as: What is a competitive level of RWE? How early should RWE generation start? What issues should RWE focus on? And how do the answers to those questions change over the launch lifecycle?

Contact Us